News Story: Full Text
Sponsored By
Cedars-Siani Medical Center Brain Tumor Program
Please Click On The Above Banner For More Details
Braintumor Website

 

Pharmacyclics Presents Data Demonstrating Xcytrin`s Novel Mechanism of Action In Cancer (PR Newswire)...Xcytrin increased cytotoxic response to bleomycin in clonogenic assays and other lab experiments, and increased tumor response to both agents in animal models.......Patient enrollment was recently completed in the company`s large international randomized Phase III study of Xcytrin for the treatment of brain metastases, i.e., advanced stage cancer that has spread from another part of the body to the brain.......Several other clinical studies are underway or being planned with Xcytrin in other tumor types, such as primary brain tumors, pancreatic cancer and non-small-cell lung cancer....- Mar 28 7:30 AM ET


IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: http://biz.yahoo.com/prnews/010328/sfw011.html


(Everything below this line is from VirtualTrials.com!)

Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740